Argus: Bioverativ Shares Fully Valued After Sanofi Buyout Offer
January 24, 2018 at 11:40 AM EST
Bioverativ Inc (NASDAQ: BIVV) agreed to be acquired by Sanofi SA (ADR) (NYSE: SNY) in an $11.6-billion all-cash deal, with the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.